Rowena Capili is a dynamic Business Operations Partner at Genentech, where she leverages over a decade of experience in the biotech, pharmaceutical, and medical device sectors to drive strategic initiatives and operational excellence. In her current role, Rowena is instrumental in designing and implementing the...
Rowena Capili is a dynamic Business Operations Partner at Genentech, where she leverages over a decade of experience in the biotech, pharmaceutical, and medical device sectors to drive strategic initiatives and operational excellence. In her current role, Rowena is instrumental in designing and implementing the strategic roadmap for her organizational areas, ensuring that high-level strategies are effectively translated into actionable plans. Her expertise in portfolio management and project management, underscored by her PMP® certification, enables her to oversee complex projects that align with Genentech's long-term objectives.
Rowena's current focus includes developing and executing organizational objectives and key results (OKRs), which are critical for measuring performance and ensuring that the right activities are executed at the right time. She is adept at navigating the intricacies of regulatory compliance, including FDA regulations and ISO 13485 standards, which are essential in the medical device industry. Her hands-on approach, characterized by a "roll up my sleeves, figure it out" mentality, has made her a key player in product launches and change control processes, driving innovation while maintaining rigorous quality systems.
In addition to her technical skills, Rowena is a passionate people manager who fosters collaboration and growth within her teams. She believes that effective sales and commercial operations are rooted in strong interpersonal relationships and clear communication. As she continues to lead key projects at Genentech, Rowena remains committed to enhancing operational efficiencies and delivering impactful results that contribute to the company's mission of transforming patient care through groundbreaking therapies.